Loop Medical
On a mission to develop an easy and painless blood collection technology making it accessible to all.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
$6.4m | Series A | ||
| Total Funding | 000k | ||
| EUR | 2015 | 2016 | 2017 | 2018 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 1 % | (8 %) | 4 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Loop Medical is a pioneering healthcare startup that has developed Onflow, a groundbreaking needle-free blood collection technology. This innovative device aims to revolutionize clinical diagnostics by making blood tests painless and accessible to all. The company primarily serves healthcare professionals and patients, offering a user-friendly device that simplifies the blood collection process while seamlessly fitting into patients' lifestyles. Operating in the medical diagnostics market, Loop Medical's business model focuses on selling its Onflow device to healthcare providers and institutions. Revenue is generated through the sale of these devices and potentially through partnerships with diagnostic labs and healthcare facilities. The company is currently in the investigational phase, with products available for investigational use only and pending submission to the US Food and Drug Administration (FDA). Loop Medical's mission is to empower patients to take control of their health by providing easy and painless blood collection technology.
Keywords: needle-free, blood collection, diagnostics, healthcare, Onflow, painless, accessible, investigational, FDA, innovation.